Skip to main content

Find Clinical Trials

Home
Conditions
Genetic Diseases, Inborn

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,633 public trials 2,161 recruiting studies

Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

NCT04447417

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Investigational Site Number 8400001 Denver, Colorado, United States

Investigational Site Number 1240001 Montreal, Canada

View Trial Details

Completed

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

NCT06436183

Conditions: Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Medical Dermatology Specialists, PC/US Dermatology Partners Phoenix, Arizona, United States

California Dermatology & Clinical Research Institute Encinitas, California, United States

First OC Dermatology Research, Inc. Fountain Valley, California, United States

Center for Dermatology Clinical Research, Inc. Fremont, California, United States

View all 35 locations

View Trial Details

Completed

The Lived Experience of People With Von Willebrand Disease

NCT06064643

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations: Oxford University Hospitals NHS Foundation Trust Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

NCT05166109

Conditions: Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +8 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

Azienda Ospedale Universita Padova Padova, Italy

View Trial Details

Completed

Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A

NCT05042440

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Investigational Site Number :1000001 Sofia, Bulgaria

View Trial Details

Completed

Prevalence and Hematological Characteristics of Hemoglobinopathies

NCT07180836

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Mardan Medical Comlex, Mardan Mardan, KPK, Pakistan

View Trial Details

Completed

Examining the Effects of Mitochondrial Oxidative Stress in DCM

NCT05410873

Conditions: Cardiomegaly, Cardiomyopathies, Cardiomyopathy, Dilated, +6 more
Locations: Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

NCT04380610

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +15 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Illinois Chicage Chicago, Illinois, United States

St Jude Childrens Research Hospital Memphis, Tennessee, United States

University of Tennessee Health Science Center Memphis, Tennessee, United States

View Trial Details

Completed

Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation

NCT05581056

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Hôpital Femme Mère Enfant Bron, Rhone, France

View Trial Details

Completed

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

NCT04033367

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Investigational Site Number :8400012 North Little Rock, Arkansas, United States

Investigational Site Number :8400002 Redwood City, California, United States

Investigational Site Number :8400001 Rolling Hills Estates, California, United States

Investigational Site Number :8400013 Colorado Springs, Colorado, United States

View all 42 locations

View Trial Details